688161 威高骨科
已收盘 11-18 15:00:00
资讯
新帖
简况
威高骨科(688161)披露续聘德勤华永为2026年度审计机构公告,11月12日股价下跌0.73%
证券之星 · 11-12
威高骨科(688161)披露续聘德勤华永为2026年度审计机构公告,11月12日股价下跌0.73%
股市必读:威高骨科新发布《山东威高骨科材料股份有限公司2026年第二次临时股东会会议资料》
证券之星 · 11-12
股市必读:威高骨科新发布《山东威高骨科材料股份有限公司2026年第二次临时股东会会议资料》
威高骨科(688161)11月2日主力资金净卖出15.01万元
证券之星 · 11-03
威高骨科(688161)11月2日主力资金净卖出15.01万元
威高骨科(688161)2026年三季报简析:净利润同比下降14.35%,公司应收账款体量较大
证券之星 · 11-01
威高骨科(688161)2026年三季报简析:净利润同比下降14.35%,公司应收账款体量较大
威高骨科(688161)9月30日股东户数1.01万户,较上期减少0.17%
证券之星 · 10-31
威高骨科(688161)9月30日股东户数1.01万户,较上期减少0.17%
价格体系调整拖累销量 威高骨科前三季度营收净利双降
东方财富网 · 10-31
价格体系调整拖累销量 威高骨科前三季度营收净利双降
图解威高骨科三季报:第三季度单季净利润同比下降30.60%
证券之星 · 10-31
图解威高骨科三季报:第三季度单季净利润同比下降30.60%
威高骨科:关于召开2026年第二次临时股东会的通知
证券日报网 · 10-30
威高骨科:关于召开2026年第二次临时股东会的通知
股市必读:威高骨科新发布《山东威高骨科材料股份有限公司2026年半年度权益分派实施公告》
证券之星 · 09-30
股市必读:威高骨科新发布《山东威高骨科材料股份有限公司2026年半年度权益分派实施公告》
威高骨科(688161)披露2026年半年度权益分派实施公告,9月28日股价下跌0.23%
证券之星 · 09-28
威高骨科(688161)披露2026年半年度权益分派实施公告,9月28日股价下跌0.23%
每周股票复盘:威高骨科(688161)将参加科创板业绩说明会
证券之星 · 09-13
每周股票复盘:威高骨科(688161)将参加科创板业绩说明会
股市必读:威高骨科新发布《关于参加科创板2026年半年度医疗器械及医疗设备行业集体业绩说明会的公告》
证券之星 · 09-10
股市必读:威高骨科新发布《关于参加科创板2026年半年度医疗器械及医疗设备行业集体业绩说明会的公告》
股市必读:威高骨科中报 - 第二季度单季净利润同比下降2.40%
证券之星 · 08-27
股市必读:威高骨科中报 - 第二季度单季净利润同比下降2.40%
威高骨科(688161)6月30日股东户数1.01万户,较上期增加5.37%
证券之星 · 08-26
威高骨科(688161)6月30日股东户数1.01万户,较上期增加5.37%
威高骨科2026年半年报:净利润下滑 7%,传统植入物板块承压
蓝鲸财经 · 08-26
威高骨科2026年半年报:净利润下滑 7%,传统植入物板块承压
图解威高骨科中报:第二季度单季净利润同比下降2.40%
证券之星 · 08-26
图解威高骨科中报:第二季度单季净利润同比下降2.40%
威高骨科(688161)披露2025年年报问询函回复公告,7月10日股价上涨2.41%
证券之星 · 07-10
威高骨科(688161)披露2025年年报问询函回复公告,7月10日股价上涨2.41%
威高骨科:每10股派发现金红利2.40元(含税)
证券之星 · 06-25
威高骨科:每10股派发现金红利2.40元(含税)
每周股票复盘:威高骨科(688161)拟每股派现0.24元
证券之星 · 06-20
每周股票复盘:威高骨科(688161)拟每股派现0.24元
威高骨科(688161)披露2025年年度权益分派实施公告,6月18日股价上涨1.96%
证券之星 · 06-18
威高骨科(688161)披露2025年年度权益分派实施公告,6月18日股价上涨1.96%
加载更多
公司概况
公司名称:
山东威高骨科材料股份有限公司
所属行业:
专用设备制造业
上市日期:
2021-06-30
主营业务:
山东威高骨科材料股份有限公司的主营业务是骨科医疗器械的研发、生产和销售。公司的主要产品是脊柱类、创伤类、关节类、运动医学类、骨修复材料类植入物、手术器械产品以及富血小板血浆(PRP)制备用套装、封闭创伤负压引流套装。
发行价格:
36.22
{"stockData":{"symbol":"688161","market":"SH","secType":"STK","nameCN":"威高骨科","latestPrice":19.32,"timestamp":1794985200000,"preClose":19.83,"halted":0,"volume":1007857,"delay":0,"changeRate":-0.0257,"floatShares":400000000,"shares":400000000,"eps":0.5973,"marketStatus":"已收盘","change":-0.51,"latestTime":"11-18 15:00:00","open":19.84,"high":20.06,"low":19.22,"amount":19649000,"amplitude":0.0424,"askPrice":19.34,"askSize":53,"bidPrice":19.32,"bidSize":633,"shortable":0,"etf":0,"ttmEps":0.5973,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795051800000},"marketStatusCode":5,"adr":0,"adjPreClose":19.83,"symbolType":"stock_kcb","openAndCloseTimeList":[[1794965400000,1794972600000],[1794978000000,1794985200000]],"highLimit":21.81,"lowLimit":17.85,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":400000000,"isCdr":false,"pbRate":1.83,"roa":"--","peRate":32.345555,"roe":"4.22%","epsLYR":0.68,"committee":0.694344,"marketValue":7728000000,"turnoverRate":0.0025,"status":1,"afterMarket":{"amount":0,"volume":0,"close":19.32,"buyVolume":0,"sellVolume":0,"time":1794987237746,"indexStatus":"已收盘 11-18 15:30:00","preClose":19.83},"floatMarketCap":7728000000},"requestUrl":"/m/hq/s/688161","defaultTab":"news","newsList":[{"id":"2682569528","title":"威高骨科(688161)披露续聘德勤华永为2026年度审计机构公告,11月12日股价下跌0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682569528","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682569528?lang=zh_cn&edition=full","pubTime":"2026-11-12 17:47","pubTimestamp":1794476870,"startTime":"0","endTime":"0","summary":"截至2026年11月12日收盘,威高骨科报收于20.52元,较前一交易日下跌0.73%,最新总市值为82.08亿元。该股当日开盘20.73元,最高20.92元,最低20.52元,成交额达1737.92万元,换手率为0.21%。近日,山东威高骨科材料股份有限公司发布《2026年第二次临时股东会会议资料》公告。公告显示,公司拟续聘德勤华永会计师事务所为2026年度财务报告及内部控制审计机构。本期审计费用为110.00万元,其中财务报表审计80.00万元,内部控制审计30.00万元,与上年持平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200032107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682584259","title":"股市必读:威高骨科新发布《山东威高骨科材料股份有限公司2026年第二次临时股东会会议资料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2682584259","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682584259?lang=zh_cn&edition=full","pubTime":"2026-11-12 03:43","pubTimestamp":1794426189,"startTime":"0","endTime":"0","summary":"截至2026年11月11日收盘,威高骨科报收于20.67元,下跌0.53%,换手率0.17%,成交量6631.0手,成交额1369.39万元。公司公告汇总山东威高骨科材料股份有限公司2026年第二次临时股东会会议资料山东威高骨科材料股份有限公司拟续聘德勤华永会计师事务所为2026年度财务报告及内部控制审计机构。项目合伙人、签字注册会计师及质量控制复核人均未受过处罚,且自2025年起为公司提供服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200004343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680792152","title":"威高骨科(688161)11月2日主力资金净卖出15.01万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680792152","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680792152?lang=zh_cn&edition=full","pubTime":"2026-11-03 08:35","pubTimestamp":1793666118,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月2日收盘,威高骨科报收于20.3元,下跌3.52%,换手率0.8%,成交量3.2万手,成交额6479.9万元。近5日资金流向一览见下表:威高骨科融资融券信息显示,融资方面,当日融资买入962.45万元,融资偿还657.32万元,融资净买入305.12万元。威高骨科主营业务:骨科医疗器械的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300010472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680827230","title":"威高骨科(688161)2026年三季报简析:净利润同比下降14.35%,公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2680827230","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680827230?lang=zh_cn&edition=full","pubTime":"2026-11-01 06:25","pubTimestamp":1793485546,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期威高骨科发布2026年三季报。截至本报告期末,公司营业总收入9.7亿元,同比下降12.28%,归母净利润1.78亿元,同比下降14.35%。按单季度数据看,第三季度营业总收入2.66亿元,同比下降27.18%,第三季度归母净利润4541.88万元,同比下降30.6%。本报告期威高骨科公司应收账款体量较大,当期应收账款占最新年报归母净利润比达145.94%。本文数据来源于威高骨科2026年三季报,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110100001421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679278205","title":"威高骨科(688161)9月30日股东户数1.01万户,较上期减少0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679278205","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679278205?lang=zh_cn&edition=full","pubTime":"2026-10-31 17:17","pubTimestamp":1793438257,"startTime":"0","endTime":"0","summary":"证券之星消息,近日威高骨科披露,截至2026年9月30日公司股东户数为1.01万户,较6月30日减少17.0户,减幅为0.17%。在医疗器械行业个股中,威高骨科股东户数低于行业平均水平,截至9月30日,医疗器械行业平均股东户数为2.11万户。从股价来看,2026年6月30日至2026年9月30日,威高骨科区间涨幅为3.86%,在此期间股东户数减少17.0户,减幅为0.17%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100033323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679220090","title":"价格体系调整拖累销量 威高骨科前三季度营收净利双降","url":"https://stock-news.laohu8.com/highlight/detail?id=2679220090","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679220090?lang=zh_cn&edition=full","pubTime":"2026-10-31 15:52","pubTimestamp":1793433135,"startTime":"0","endTime":"0","summary":"10月29日晚间,威高骨科(688161.SH)披露2026年第三季度报告,1—9月份实现营业收入9.70亿元,同比下降12.27%;归属于上市公司股东的净利润1.78亿元,同比下降14.35%,营收、净利双双下滑。业绩承压的根源,指向集采窗口期渠道产品库存结构与价格体系调整带来的销量收缩。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11134,202610313917601396.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11134,202610313917601396.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679244470","title":"图解威高骨科三季报:第三季度单季净利润同比下降30.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679244470","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679244470?lang=zh_cn&edition=full","pubTime":"2026-10-31 02:38","pubTimestamp":1793385516,"startTime":"0","endTime":"0","summary":"证券之星消息,威高骨科2026年三季报显示,前三季度公司主营收入9.7亿元,同比下降12.28%;归母净利润1.78亿元,同比下降14.35%;扣非净利润1.73亿元,同比下降11.12%;其中2026年第三季度,公司单季度主营收入2.66亿元,同比下降27.18%;单季度归母净利润4541.88万元,同比下降30.6%;单季度扣非净利润4691.43万元,同比下降20.01%;负债率17.84%,投资收益2353.23万元,财务费用142.47万元,毛利率63.67%。财报数据概要请见下图:本文数据来源于威高骨科2026年三季报,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100004203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679435092","title":"威高骨科:关于召开2026年第二次临时股东会的通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2679435092","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679435092?lang=zh_cn&edition=full","pubTime":"2026-10-30 21:36","pubTimestamp":1793367360,"startTime":"0","endTime":"0","summary":"证券日报网讯 10月30日,威高骨科发布公告称,公司将于2026年11月19日召开2026年第二次临时股东会。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-30/doc-iniwzprp8059315.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-30/doc-iniwzprp8059315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671447332","title":"股市必读:威高骨科新发布《山东威高骨科材料股份有限公司2026年半年度权益分派实施公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671447332","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671447332?lang=zh_cn&edition=full","pubTime":"2026-09-30 03:09","pubTimestamp":1790708952,"startTime":"0","endTime":"0","summary":"截至2026年9月29日收盘,威高骨科报收于21.76元,上涨0.79%,换手率0.15%,成交量6128.0手,成交额1334.68万元。当日关注点交易信息汇总:9月29日主力资金净流入41.92万元,占总成交额3.14%。公司公告汇总:威高骨科将于2026年10月13日发放2026年半年度现金红利,每股0.09元(含税),总额3575.58万元(含税),差异化分红依据回购股份剔除安排执行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000002891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670552762","title":"威高骨科(688161)披露2026年半年度权益分派实施公告,9月28日股价下跌0.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670552762","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670552762?lang=zh_cn&edition=full","pubTime":"2026-09-28 22:40","pubTimestamp":1790606438,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘,威高骨科报收于21.59元,较前一交易日下跌0.23%,最新总市值为86.36亿元。该股当日开盘21.8元,最高21.83元,最低21.33元,成交额达1501.95万元,换手率为0.17%。近日,山东威高骨科材料股份有限公司发布《2026年半年度权益分派实施公告》。股权登记日为2026年10月12日,除权(息)日和现金红利发放日均为2026年10月13日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800035388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667001365","title":"每周股票复盘:威高骨科(688161)将参加科创板业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2667001365","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667001365?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:31","pubTimestamp":1789241469,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘,威高骨科报收于21.65元,较上周的22.4元下跌3.35%。本周,威高骨科9月10日盘中最高价报23.25元。9月11日盘中最低价报21.35元。威高骨科当前最新总市值86.6亿元,在医疗器械板块市值排名31/129,在两市A股市值排名2026/5218。本周关注点公司公告汇总:威高骨科将参加科创板2026年半年度行业集体业绩说明会。投资者可于2026年9月10日至9月16日16:00前通过上证路演中心网站或公司邮箱ir@wegortho.com提交问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300001282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666402534","title":"股市必读:威高骨科新发布《关于参加科创板2026年半年度医疗器械及医疗设备行业集体业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666402534","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666402534?lang=zh_cn&edition=full","pubTime":"2026-09-10 01:13","pubTimestamp":1788973990,"startTime":"0","endTime":"0","summary":"截至2026年9月9日收盘,威高骨科报收于22.32元,下跌0.4%,换手率0.34%,成交量1.36万手,成交额3020.55万元。当日关注点交易信息汇总:9月9日主力资金净流入286.32万元,占总成交额9.48%。公司公告汇总:威高骨科将于9月17日15:00–17:00通过上证路演中心参加科创板医疗器械及医疗设备行业集体业绩说明会,就2026年半年度经营成果与财务状况与投资者交流。投资者可于2026年9月10日至9月16日16:00前通过上证路演中心网站或公司邮箱ir@wegortho.com提交问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000001870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK1574","09996","BK1100","BK0251","159883","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662403417","title":"股市必读:威高骨科中报 - 第二季度单季净利润同比下降2.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662403417","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662403417?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:03","pubTimestamp":1787781816,"startTime":"0","endTime":"0","summary":"截至2026年8月26日收盘,威高骨科报收于22.09元,下跌1.12%,换手率0.3%,成交量1.19万手,成交额2642.16万元。业绩披露要点财务报告2026年中报显示,上半年度公司主营收入7.04亿元,同比下降4.93%;归母净利润1.32亿元,同比下降6.85%;扣非净利润1.26亿元,同比下降7.28%;其中第二季度单季度主营收入4.08亿元,同比下降9.46%;单季度归母净利润8800.19万元,同比下降2.4%;单季度扣非净利润8504.89万元,同比下降1.94%;负债率18.74%,投资收益1393.34万元,财务费用83.55万元,毛利率63.57%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700010843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662944677","title":"威高骨科(688161)6月30日股东户数1.01万户,较上期增加5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662944677","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662944677?lang=zh_cn&edition=full","pubTime":"2026-08-26 17:36","pubTimestamp":1787736995,"startTime":"0","endTime":"0","summary":"证券之星消息,近日威高骨科披露,截至2026年6月30日公司股东户数为1.01万户,较3月31日增加516.0户,增幅为5.37%。在医疗器械行业个股中,威高骨科股东户数低于行业平均水平,截至6月30日,医疗器械行业平均股东户数为2.13万户。从股价来看,2026年3月31日至2026年6月30日,威高骨科区间跌幅为31.08%,在此期间股东户数增加516.0户,增幅为5.37%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600039491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662679336","title":"威高骨科2026年半年报:净利润下滑 7%,传统植入物板块承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2662679336","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662679336?lang=zh_cn&edition=full","pubTime":"2026-08-26 15:19","pubTimestamp":1787728787,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月26日讯,8月25日,山东威高骨科材料股份有限公司 披露 2026 年半年度财报,年初至报告期末实现营业收入 7.04 亿元,同比下降 4.93%;归属于上市公司股东的净利润 1.32 亿元,同比下降 6.85%。报告期内,公司脊柱、创伤、关节等传统核心植入物板块销量承压,主要系市场竞争加剧导致短期需求波动;然而,运动医学产品线聚焦专科赛道深耕,报告期内实现营业收入 4,169.63 万元,同比大幅增长 172.97%,成为业绩重要增量来源。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787707345266563944","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662759105","title":"图解威高骨科中报:第二季度单季净利润同比下降2.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662759105","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662759105?lang=zh_cn&edition=full","pubTime":"2026-08-26 01:43","pubTimestamp":1787679788,"startTime":"0","endTime":"0","summary":"证券之星消息,威高骨科2026年中报显示,上半年度公司主营收入7.04亿元,同比下降4.93%;归母净利润1.32亿元,同比下降6.85%;扣非净利润1.26亿元,同比下降7.28%;其中2026年第二季度,公司单季度主营收入4.08亿元,同比下降9.46%;单季度归母净利润8800.19万元,同比下降2.4%;单季度扣非净利润8504.89万元,同比下降1.94%;负债率18.74%,投资收益1393.34万元,财务费用83.55万元,毛利率63.57%。财报数据概要请见下图:本文数据来源于威高骨科2026年中报,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600004246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650513691","title":"威高骨科(688161)披露2025年年报问询函回复公告,7月10日股价上涨2.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650513691","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650513691?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:49","pubTimestamp":1783694949,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘,威高骨科报收于22.07元,较前一交易日上涨2.41%,最新总市值为88.28亿元。该股当日开盘21.72元,最高22.35元,最低21.25元,成交额达2716.49万元,换手率为0.31%。近日,山东威高骨科材料股份有限公司发布《关于2025年年报问询函回复的公告》。境外收入同比增长59.70%,主要因脊柱和关节产品销量上升。公司销售模式转型致销售费用下降12.05%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000045071.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646382064","title":"威高骨科:每10股派发现金红利2.40元(含税)","url":"https://stock-news.laohu8.com/highlight/detail?id=2646382064","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646382064?lang=zh_cn&edition=full","pubTime":"2026-06-25 15:37","pubTimestamp":1782373056,"startTime":"0","endTime":"0","summary":"证券之星消息,威高骨科06月25日在投资者关系平台上答复投资者关心的问题。另外,公司加大分红力度,截至目前,公司完成现金分红金额总计5.75亿元,占归母净利润的比例超过33%。公司将在6月26号实施2025年年度权益分派,每10股派发现金红利2.40元(含税),派发现金分红总额共计95,348,669.76元(含税),约占2025年度归母净利润的35.49%。股票价格受宏观环境、市场资金投资偏好分化等多重外部因素影响,敬请投资者注意短期投资风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500022931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644065057","title":"每周股票复盘:威高骨科(688161)拟每股派现0.24元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644065057","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644065057?lang=zh_cn&edition=full","pubTime":"2026-06-20 03:22","pubTimestamp":1781896933,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,威高骨科报收于21.84元,较上周的22.32元下跌2.15%。本周,威高骨科6月15日盘中最高价报22.66元。威高骨科当前最新总市值87.36亿元,在医疗器械板块市值排名31/129,在两市A股市值排名2181/5206。本周关注点公司公告汇总:威高骨科2025年年度权益分派实施公告显示,每股现金红利0.24元(含税),股权登记日为2026年6月25日。公司公告汇总:本次权益分派合计派发现金红利95,348,669.76元(含税),占2025年度合并归属于公司股东净利润的35.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000001998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644828690","title":"威高骨科(688161)披露2025年年度权益分派实施公告,6月18日股价上涨1.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644828690","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644828690?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:54","pubTimestamp":1781794458,"startTime":"0","endTime":"0","summary":"近日,公司发布《山东威高骨科材料股份有限公司2025年年度权益分派实施公告》:每股现金红利0.24元(含税),股权登记日为2026年6月25日,除权(息)日及现金红利发放日均为2026年6月26日。本次利润分配以实施权益分派时股权登记日的总股本扣减回购专用账户股份后的股份数为基数,合计派发现金红利95,348,669.76元(含税),占2025年度合并归属于公司股东净利润的35.49%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800043049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794989314928,"stockEarnings":[{"period":"1week","weight":-0.0457},{"period":"1month","weight":-0.0895},{"period":"3month","weight":-0.0846},{"period":"6month","weight":-0.2381},{"period":"1year","weight":-0.3387},{"period":"ytd","weight":-0.2788}],"compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":-0.0354},{"period":"3month","weight":-0.0796},{"period":"6month","weight":-0.1208},{"period":"1year","weight":-0.0975},{"period":"ytd","weight":-0.0968}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东威高骨科材料股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"10102人(较上一季度减少0.17%)","perCapita":"39596股","listingDate":"2021-06-30","address":"山东省威海市环翠区旅游度假区香江街26号","registeredCapital":"40000万元","survey":" 山东威高骨科材料股份有限公司的主营业务是骨科医疗器械的研发、生产和销售。公司的主要产品是脊柱类、创伤类、关节类、运动医学类、骨修复材料类植入物、手术器械产品以及富血小板血浆(PRP)制备用套装、封闭创伤负压引流套装。","listedPrice":36.22},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"威高骨科(688161)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供威高骨科(688161)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"威高骨科,688161,威高骨科股票,威高骨科股票老虎,威高骨科股票老虎国际,威高骨科行情,威高骨科股票行情,威高骨科股价,威高骨科股市,威高骨科股票价格,威高骨科股票交易,威高骨科股票购买,威高骨科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"威高骨科(688161)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供威高骨科(688161)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}